dc.contributor.author |
Bubenyák, Máté Dániel |
|
dc.contributor.author |
Noszál, Béla |
|
dc.contributor.author |
Koczian K, |
|
dc.contributor.author |
Takacs M, |
|
dc.contributor.author |
Béni, Szabolcs |
|
dc.contributor.author |
Hermecz, István |
|
dc.contributor.author |
Kökösi, József |
|
dc.date.accessioned |
2016-02-18T12:35:32Z |
|
dc.date.available |
2016-02-18T12:35:32Z |
|
dc.date.issued |
2008 |
|
dc.identifier |
49549090662 |
|
dc.identifier.citation |
pagination=5711-5713;
journalVolume=49;
journalIssueNumber=40;
journalTitle=TETRAHEDRON LETTERS; |
|
dc.identifier.uri |
http://repo.lib.semmelweis.hu//handle/123456789/3092 |
|
dc.identifier.uri |
doi:10.1016/j.tetlet.2008.07.098 |
|
dc.description.abstract |
Bioisosteric replacements were accomplished by building the structural elements of piroxicam, an antiinflammatory drug, into the pentacyclic system of rutaecarpine, a quinazolinocarboline alkaloid, in order to modify activity and selectivity on COX-isoenzymes. The pentacyclic compounds were synthesized efficiently by employing 1-oxo-9,10,11,12-tetrahydro-4H-pyrido[1,2-b] 1,2-benzothiazine 5,5-dioxide as a key intermediate, and prepared by alternative routes. Condensation of the tricyclic ketone with arylhydrazines and subsequent Fischer-indolization provided the first representatives of new heterocyclic ring systems 3 and 4. Crown Copyright (C) 2008 Published by Elsevier Ltd. All Fights reserved. |
|
dc.relation.ispartof |
urn:issn:0040-4039 |
|
dc.title |
Bioisosteric hybrids of two anti-inflammatory agents, rutaecarpine and piroxicam |
|
dc.type |
Journal Article |
|
dc.date.updated |
2016-02-15T10:12:03Z |
|
dc.language.rfc3066 |
en |
|
dc.identifier.mtmt |
1475845 |
|
dc.identifier.wos |
000259537800001 |
|
dc.contributor.department |
SE/GYTK/Egyetemi Gyógyszertár Gyógyszerügyi Szervezési Intézet |
|
dc.contributor.department |
SE/GYTK/Gyógyszerészi Kémiai Intézet |
|
dc.contributor.institution |
Semmelweis Egyetem |
|